Feds Say Scios Mislabeled Heart Drug Natrecor
Federal prosecutors in California on Thursday criminally charged Johnson & Johnson subsidiary Scios Inc. with mislabeling Natrecor, a drug used to treat a type of heart failure....To view the full article, register now.
Already a subscriber? Click here to view full article